The text discusses the challenges clinicians face in applying gastroenterology research findings to patient care, emphasizing the importance of evaluating study design, patient demographics, and trial characteristics. It highlights the significance of placebo comparators, blinding, and intention-to-treat analysis in clinical trials, as well as the different types of trial designs. The text stresses the need for clinicians to carefully assess the validity of surrogate outcomes and endpoints, particularly in the context of inflammatory bowel disease treatments. It also discusses the impact of sample size on study outcomes, the importance of considering dropout rates, and the significance of using appropriate statistical methods in clinical trials. Additionally, the text suggests considering various study designs beyond randomized controlled trials and emphasizes the importance of presenting data variability accurately.